Turkish Journal of Oncology Turkish Society for Radiation Oncology
Article Open Access Volume 27 · Issue 1 · 2012 pp. 017–023

The value of the expressions of E-cadherin, Calretinin and GLUT-1 in the differential diagnosis of malignant mesothelioma, reactive mesothelial proliferation and adenocarcinoma in serous effusions

Sevcihan MUTLU1
1 İstanbul Üniversitesi Onkoloji Enstitüsü, Onkolojik Sitoloji Bilim Dalı, İstanbul
2 İstanbul Üniversitesi Onkoloji Enstitüsü, Tümör Patolojisi Bilim Dalı, İstanbul
Published: 2012 Article ID: 801
Abstract
OBJECTIVES

The aim of the study was to establish the value of E-cadherin,
Calretinin and GLUT-1 antibodies in serous effusions in the
differential diagnosis of malignant mesothelioma, reactive
mesothelial proliferation and adenocarcinoma using immunocytochemical
method.


METHODS

The study group consisted of the cell blocks from 60 patients,
with 20 in each of the three groups. Immunocytochemistry
staining method was applied to the sections prepared from the
cell blocks of the selected cases.


RESULTS

In this study, strong expression of E-cadherin antibody in adenocarcinoma,
strong expression of Calretinin antibody in mesothelioma
and reactive mesothelial proliferation, and strong
expression of GLUT-1 antibody in mesothelioma and adenocarcinoma
were established.


CONCLUSION

The results of the present study revealed that E-cadherin antibody
can be successfully used as a marker for the differentiation
of adenocarcinoma from mesothelioma and reactive
mesothelial proliferation, Calretinin antibody can be used for
the differentiation of mesothelioma and reactive mesothelial
proliferation from adenocarcinoma, and GLUT-1 antibody can
be used for the differentiation of adenocarcinoma and mesothelioma
from reactive mesothelial proliferation.

Keywords: Adenocarcinoma; E-cadherin; GLUT-1; Calretinin; mesothelioma; reactive mesothelial proliferation

Article information

6,747 Views
3,303 Downloads
View / Download PDF

Current Issue Vol 27 · Iss 1

Submit manuscript
Most read & early access
Click an article to open abstract.
No early access articles.
View all articles